- Home
- SOPH vs CMPS Comparison
SOPH vs CMPS Comparison
Compare SOPH & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- CMPS
- Stock Information
- Founded
- SOPH 2011
- CMPS 2020
- Country
- SOPH Switzerland
- CMPS United Kingdom
- Employees
- SOPH N/A
- CMPS N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- SOPH Health Care
- CMPS Health Care
- Exchange
- SOPH Nasdaq
- CMPS Nasdaq
- Market Cap
- SOPH 206.6M
- CMPS 246.5M
- IPO Year
- SOPH 2021
- CMPS 2020
- Fundamental
- Price
- SOPH $2.93
- CMPS $3.79
- Analyst Decision
- SOPH Strong Buy
- CMPS Strong Buy
- Analyst Count
- SOPH 2
- CMPS 6
- Target Price
- SOPH $6.50
- CMPS $20.20
- AVG Volume (30 Days)
- SOPH 26.9K
- CMPS 857.9K
- Earning Date
- SOPH 05-06-2025
- CMPS 05-08-2025
- Dividend Yield
- SOPH N/A
- CMPS N/A
- EPS Growth
- SOPH N/A
- CMPS N/A
- EPS
- SOPH N/A
- CMPS N/A
- Revenue
- SOPH $67,173,000.00
- CMPS N/A
- Revenue This Year
- SOPH $14.86
- CMPS N/A
- Revenue Next Year
- SOPH $22.76
- CMPS N/A
- P/E Ratio
- SOPH N/A
- CMPS N/A
- Revenue Growth
- SOPH 4.66
- CMPS N/A
- 52 Week Low
- SOPH $2.58
- CMPS $2.49
- 52 Week High
- SOPH $6.28
- CMPS $9.63
- Technical
- Relative Strength Index (RSI)
- SOPH 44.97
- CMPS 55.32
- Support Level
- SOPH $2.90
- CMPS $3.62
- Resistance Level
- SOPH $3.33
- CMPS $4.00
- Average True Range (ATR)
- SOPH 0.21
- CMPS 0.29
- MACD
- SOPH 0.00
- CMPS -0.00
- Stochastic Oscillator
- SOPH 21.78
- CMPS 44.57
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.